Globus Medical Reports Fourth Quarter and Full Year 2019 Results
February 20, 2020 16:15 ET
|
Globus Medical
AUDUBON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year...
Globus Medical Schedules Fourth Quarter and Full Year 2019 Earnings Release and Conference Call
February 06, 2020 16:30 ET
|
Globus Medical
AUDUBON, Pa, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year...
MicroCures Awarded $1.5M SBIR Grant To Support Development of Novel Therapeutic Platform for Accelerated Tissue Repair
January 07, 2020 08:05 ET
|
MicroCures, Inc.
NEW YORK, Jan. 07, 2020 (GLOBE NEWSWIRE) -- MicroCures, a biopharmaceutical company developing novel therapeutics that harness the body’s innate regenerative mechanisms to accelerate tissue repair,...
Globus Medical Reports Third Quarter 2019 Results
November 06, 2019 16:15 ET
|
Globus Medical
AUDUBON, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended...
Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting
September 24, 2019 08:30 ET
|
Globus Medical
AUDUBON, Pa., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of the AUTOBAHN® Nailing System. This...
FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury
August 28, 2019 08:00 ET
|
SHINKEI Therapeutics
PRINCETON, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics., a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous...
Globus Medical Schedules Second Quarter 2019 Earnings Release and Conference Call
July 15, 2019 08:00 ET
|
Globus Medical
AUDUBON, Pa., July 15, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June...
Europe Blood and Blood Components Market to hit $5 billion by 2024: Global Market Insights, Inc.
June 19, 2019 01:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, June 19, 2019 (GLOBE NEWSWIRE) -- Russia blood and blood components market is estimated to witness fastest growth to reach USD 840 million by 2024. Growing geriatric...
Globus Medical Reports First Quarter 2019 Results
May 02, 2019 16:15 ET
|
Globus Medical
AUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended...
Globus Medical Reports Full Year and Fourth Quarter 2018 Results
February 21, 2019 16:15 ET
|
Globus Medical
AUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year...